Which companies discussed China Exposure in Health Care in earnings calls?

509 companies mentioned china exposure across 1,489 earnings calls in Health Care over the past year, spanning 1 sectors. The most active were Merck KGaA (21 calls), Revvity, Inc. (16 calls), Charles River Laboratories International, Inc. (14 calls). The table below ranks every company by how often the theme came up, with direct links to each transcript.

Mentions over time

Data table
QuarterCalls mentioning China Exposure
2024Q4367
2025Q1465
2025Q2392
2025Q3412
2025Q4342
2026Q1419
2026Q2332
2026Q3397
2026Q47

Companies ranked by mentions

Company Ticker Sector Calls Last mention
Merck KGaA MRK Health Care 21 Sep 14, 2026
Revvity, Inc. RVTY Health Care 16 Sep 15, 2026
Charles River Laboratories International, Inc. CRL Health Care 14 Sep 24, 2026
Repligen Corporation RGEN Health Care 14 Sep 9, 2026
Pfizer Inc. PFE Health Care 13 Sep 22, 2026
Bio-Techne Corporation TECH Health Care 13 May 12, 2026
GSK plc GSK Health Care 12 Sep 23, 2026
Royalty Pharma plc RPRX Health Care 12 Sep 23, 2026
Align Technology, Inc. ALGN Health Care 12 Sep 15, 2026
Cytokinetics, Incorporated CYTK Health Care 11 Sep 14, 2026
Summit Therapeutics Inc. SMMT Health Care 11 Jul 23, 2026
Vertex Pharmaceuticals Incorporated VRTX Health Care 10 Sep 23, 2026
Waters Corporation WAT Health Care 10 Sep 23, 2026
Bruker Corporation BRKR Health Care 10 Sep 22, 2026
Qiagen N.V. QGEN Health Care 10 Sep 15, 2026
Nuvation Bio Inc. NUVB Health Care 10 Sep 9, 2026
GE HealthCare Technologies Inc. GEHC Health Care 10 Sep 9, 2026
Bayer Aktiengesellschaft BAYN Health Care 10 Sep 8, 2026
Novartis AG NOVN Health Care 10 Jul 21, 2026
Johnson & Johnson JNJ Health Care 9 Oct 13, 2026
Agilent Technologies, Inc. A Health Care 9 Sep 23, 2026
Viatris Inc. VTRS Health Care 9 Aug 6, 2026
Siemens Healthineers AG SHL Health Care 9 Jul 31, 2026
Bio-Rad Laboratories, Inc. BIO Health Care 8 Sep 24, 2026
Telix Pharmaceuticals Limited TLX Health Care 8 Sep 22, 2026
Envista Holdings Corporation NVST Health Care 8 Sep 17, 2026
Arrowhead Pharmaceuticals, Inc. ARWR Health Care 8 Sep 15, 2026
Lyell Immunopharma, Inc. LYEL Health Care 8 Sep 15, 2026
Thermo Fisher Scientific Inc. TMO Health Care 8 Sep 15, 2026
BeOne Medicines AG ONC Health Care 8 Sep 14, 2026
Regeneron Pharmaceuticals, Inc. REGN Health Care 8 Sep 9, 2026
Eli Lilly and Company LLY Health Care 8 Aug 5, 2026
Daiichi Sankyo Company, Limited 4568 Health Care 8 Jul 31, 2026
Mettler-Toledo International Inc. MTD Health Care 8 Jul 31, 2026
Bausch Health Companies Inc. BHC Health Care 8 Jul 29, 2026
Sanofi SAN Health Care 7 Sep 15, 2026
Oxford Nanopore Technologies plc ONT Health Care 7 Sep 15, 2026
West Pharmaceutical Services, Inc. WST Health Care 7 Sep 14, 2026
Takeda Pharmaceutical Company Limited 4502 Health Care 7 Sep 14, 2026
Becton, Dickinson and Company BDX Health Care 7 Sep 9, 2026
AstraZeneca PLC AZN Health Care 7 Sep 8, 2026
Belite Bio, Inc BLTE Health Care 7 Sep 2, 2026
Zai Lab Limited ZLAB Health Care 7 Aug 6, 2026
Haleon plc HLN Health Care 7 Jul 30, 2026
Illumina, Inc. ILMN Health Care 7 Jul 30, 2026
Merit Medical Systems, Inc. MMSI Health Care 7 Jul 30, 2026
Bausch + Lomb Corporation BLCO Health Care 7 Jul 29, 2026
Boston Scientific Corporation BSX Health Care 7 Jul 29, 2026
Roche Holding AG ROG Health Care 7 Jul 23, 2026
Danaher Corporation DHR Health Care 7 Jul 21, 2026

Representative quotes

…stocking of spares and the ability to service customers very, very easy. We also have regional hubs in Ireland, Singapore, Taiwan and China as well as Dubai. And we also have a presence in Australia. We're in Melbourne as well as Brisbane in the Monash University incubator…
— Clever Culture Systems Limited (CC5), October 14, 2026. Read the full transcript →
…assets that, of course, did not have this durability. I think 2 that you're all aware of, 1 is our site in China that actually was invested into and then closed with a small biologic sites for DS and DP. And then, of course, the Moderna investment…
— Lonza Group AG (LONN), October 14, 2026. Read the full transcript →
…take this away from looking at the data is the consistency around what we saw in vivo, what they reported out of China and now what we're seeing in the U.S. And I think what differentiates this molecule from a lot of others in the space…
— Verastem, Inc. (VSTM), October 14, 2026. Read the full transcript →
…including a negative impact of approximately 30 basis points from divestitures. The decline is more notably driven by ongoing expansion of VBP in China, surgery transformation program outcomes across the portfolio and Middle East disruption, which impacted tender timing and ordering patterns. The decline was partially offset…
— Johnson & Johnson (JNJ), October 13, 2026. Read the full transcript →

Frequently asked questions

What is China Exposure and why are companies discussing it?

Demand, competition and geopolitical risk in China as management teams weigh exposure to the world's second-largest economy.

Which company mentioned china exposure most in Health Care in the past year?

Merck KGaA (MRK) led with 21 calls referencing china exposure, most recently on September 14, 2026.

How can I track china exposure mentions across earnings calls via API?

The EarningsCalls.dev REST API exposes the same data behind this page. Use the search_transcripts and count_mentions_by_ticker endpoints to query our archive of 33,000+ earnings call transcripts — keyword search, sector / date filters, per-company mention counts, and the underlying full transcripts. See the API docs →

Related macro themes

Last updated: October 15, 2026. Methodology: full-text search across all earnings call transcripts in our corpus over the past 12 months, matching the canonical term and its aliases (China, china, chinese market). Mentions are per call, not per occurrence within a call; the company-rank table is built by counting distinct calls mentioning the theme. Page refreshes every hour at the edge as new calls land in our archive.